Abbey Coffin with Donoghue, Barrett & Singal to Speak at TKG’s The 340B Drug Pricing Program Event

Abbey Coffin with Donoghue, Barrett & Singal to Speak at TKG’s The 340B Drug Pricing Program Event on January 19, 2017

Online PR News – 09-January-2017 – New York, NY – Abbey Coffin, Attorney with Donoghue, Barrett & Singal to Speak at The Knowledge Group’s The 340B Drug Pricing Program: Practical Tips to Ensure Compliance

The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Abbey Coffin, Attorney with Donoghue, Barrett & Singal will speak at The Knowledge Group’s webcast entitled: “The 340B Drug Pricing Program: Practical Tips to Ensure Compliance.” This event is scheduled for January 19, 2017 from 12:00pm – 2:00pm (ET).

For further details, please visit:

About Abbey Coffin

Abbey Coffin is an associate in Donoghue Barrett & Singal’s Health Law practice where she provides services and consultation to hospitals, clinics, physicians, and other health care providers and suppliers. Abbey advises clients on a broad range of issues, including patient care, data privacy and security, corporate and transactional issues, policy development, clinical research compliance, risk management, and general regulatory compliance. She also counsels clients on how to achieve compliance with the 340B Drug Pricing Program rules and regulations.

Prior to joining Donoghue Barrett & Singal, Abbey worked in the technology transfer office at an academic medical center in Boston, Massachusetts where she was responsible for drafting and negotiating a variety of basic science and clinical research agreements.

About Donoghue Barrett & Singal

Donoghue Barrett & Singal is a full-service law firm that provides integrated legal services from its offices in Boston, Massachusetts and Providence, Rhode Island. The firm’s primary areas of practice are health care, corporate, litigation (complex civil and white-collar criminal), and government relations. Founded in 1989, the firm serves a growing list of clients, ranging from individuals to Fortune 500 companies. The firm acts in a variety of roles as clients’ needs dictate, from general counsel, to advisor on important transactions, to litigator in complex civil matters, to counsel for the defense in criminal cases.

Donoghue Barrett & Singal combines deep industry knowledge, dynamic thinking, and a collaborative approach to help clients achieve their most important objectives.


Implementing an efficient and effective 340B Drug Pricing Program is an unnerving task. One of the challenges encountered by numerous covered entities when complying with the requirements of the 340B Program is the lack of clarity around the rules and regulations. The vagueness and complexity of rules can result in lost savings and an increased risk of noncompliance. In order to avoid such risks, it is necessary to develop policies and procedures that are in line with the framework of the 340B Program, maintain auditable records, conduct rigorous internal and external monitoring, and respond promptly to issues in the 340B compliance process.

In this LIVE Webcast, a seasoned panel of thought leaders and professionals assembled by The Knowledge Group will provide the audience with an in-depth analysis of the contextual and hot button compliance issues surrounding 340B. Speakers will also offer practical tips in navigating the complexity and the lack of clarity around issues like patient definition and duplicate discounts.

Key topics include:

- Overview of the 340B Drug Pricing Program
- Legislative and Regulatory Updates
- Covered Entity Eligibility and Patient Definition
- Significance of HRSA
- Contextual and Compliance Issues
- Contract Pharmacies
- Self-Reporting Noncompliance
- What’s Next for the 340B Program?

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: